Photosensitive type vitreous injectable gel as well as preparation method and application thereof
A light-sensitive, gel-based technology, applied in photodynamic therapy, liquid delivery, pharmaceutical formulations, etc., can solve the problems of retinal detachment, restriction of clinical application, weak penetration of low-band light, etc., and achieve drug half-life prolongation, treatment The effect of rich targets and controllable drug release behavior
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Evaluation of rhein & baicalin synergistically resisting "angiogenesis-oxidative damage" and inducing mitophagy in vitro
[0042] HUVEC cells and ARPE-19 cells in the logarithmic growth phase were seeded in 12-well plates, and incubated at 37°C, 5% CO 2 Cultured in an incubator for 24 hours to make the cells adhere to the wall. After starving the cells with basic DMEM / F12 medium for 12 hours, discard the culture medium; carry out H 2 o 2 or CoCl 2 Modeling, set blank group, model group, drug group (model+drug) and cell co-incubation, the drug group in this example is rhein+baicalin (1 / 200, w / w), after continuing to cultivate for 24h, collect The supernatants of the cells in each group were then subjected to relevant experimental procedures according to the instructions of the rat vascular endothelial growth factor (VEGF) enzyme-linked immunosorbent assay kit. At a wavelength of 450 nm on a microplate reader, measure the absorbance (A) value of each group of cells, an...
Embodiment 2
[0048] Ligustrazine & Paeoniflorin synergistically resisting "angiogenesis-oxidative damage" and inducing mitophagy in vitro
[0049] HUVEC cells and ARPE-19 cells in the logarithmic growth phase were seeded in 12-well plates, and incubated at 37°C, 5% CO 2 Cultured in an incubator for 24 hours to make the cells adhere to the wall. After starving the cells with basic DMEM / F12 medium for 12 hours, discard the culture medium; carry out H 2 o 2 or CoCl 2 Modeling, set blank group, model group, drug group (model+drug) and co-incubation with cells, the drug group in this example is ligustrazine+paeoniflorin (200 / 1, w / w), after continuing to cultivate for 24h, collect The supernatants of the cells in each group were then subjected to relevant experimental procedures according to the instructions of the rat vascular endothelial growth factor (VEGF) enzyme-linked immunosorbent assay kit. At a wavelength of 450 nm on a microplate reader, measure the absorbance (A) value of each grou...
Embodiment 3
[0055] Evaluation of Tanshinone IIA & saikosaponin synergistically resisting "angiogenesis-oxidative damage" and inducing mitophagy in vitro
[0056] HUVEC cells and ARPE-19 cells in the logarithmic growth phase were seeded in 12-well plates, and incubated at 37°C, 5% CO 2 Cultured in an incubator for 24 hours to make the cells adhere to the wall. After starving the cells with basic DMEM / F12 medium for 12 hours, discard the culture medium; carry out H 2 o 2 or CoCl 2 Modeling, set blank group, model group, drug group (model+drug) and co-incubation with cells, the drug group in this example is Tanshinone IIA+saikosaponin (1 / 2, w / w), after continuing to cultivate for 24h, collect The supernatants of the cells in each group were then subjected to relevant experimental procedures according to the instructions of the rat vascular endothelial growth factor (VEGF) enzyme-linked immunosorbent assay kit. At a wavelength of 450 nm on a microplate reader, measure the absorbance (A) va...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com